Penserra Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Penserra Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-215	Closed	-$11K	–	1431
2021 Q3	$11K	Buy	215 +50	+30%	+$2.97K	﹤0.01%	1345
2021 Q2	$11K	Buy	165 +45	+38%	+$3.43K	﹤0.01%	1266
2021 Q1	$9K	Sell	120 -35	-23%	-$3.22K	﹤0.01%	1045
2020 Q4	$15K	Buy	155 +93	+150%	+$11.4K	﹤0.01%	884
2020 Q3	$8K	Buy	+62	New	+$10.3K	﹤0.01%	835

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Penserra Capital Management's LKFT Position: Q4 2021 in Review

Penserra Capital Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2021, closing a stake of 215 shares — an estimated $11K sold.

Penserra Capital Management first reported a position in LKFT in Q3 2020 and held it in 5 quarters. The position peaked at $15K in Q4 2020. 83 funds tracked by Wall St. Rank hold LKFT as of Q4 2021.

Penserra Capital Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Penserra Capital Management sold 215 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2021, an estimated $11K.
Penserra Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2020 and held it in 5 quarters.
Penserra Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $15K in Q4 2020.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.